Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
-
A8436 GabapentinSummary: GABA enhancer
-
A8446 IbuprofenTarget: COXSummary: inhibitor of cyclooxygenase 1 and cyclooxygenase 2
-
A8449 IndomethacinTarget: COXSummary: Cox inhibitor
-
A8465 LY28867211 CitationTarget: BACESummary: BACE inhibitor
-
A8466 Meloxicam (Mobic)Target: COXSummary: Nonsteroidal anti-inflammatory drug
-
A8496 PaliperidoneTarget: 5-HT2 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|Histamine H1 ReceptorsSummary: Dopamine receptor antagonist
-
A8503 PiroxicamTarget: COX|Prostaglandin synthesisSummary: Prostaglandin synthesis/Coxinhibitor
-
A8389 Carbenoxolone disodium1 CitationTarget: Gap JunctionsSummary: 11β-HSD inhibitor
-
B3224 AZD3839Target: BACESummary: BACE1 inhibitor,potent and selective
-
A1096 type II collagen fragmentSummary: Specific for cartilaginous tissues